Nexxt receives FDA Clearance for NEXXT MATRIXX™ system

Image Nexxt Matrixx website:

Nexxt Spine, LLC, a medical device company focused on designing, manufacturing, and distributing innovative spinal solutions, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the NEXXT MATRIXX™ System.

The NEXXT MATRIXX™ System of 3D printed porous titanium leverages Nexxt generation technology to create interbody and VBR devices with optimized open architectural porosity, residue-free surface technology, and robust radiographic imaging performance.

With these studies in mind, Nexxt Spine has coupled its proprietary, residue-free, surface technology with an open, varied porosity, titanium architecture whereby the NEXXT MATRIXX™ implants exhibit up to 4× more surface area for bone apposition and up to 2× more open pore volume than conventional spinal implants.

The first products to feature the NEXXT MATRIXX™ technology are available in both interbody and VBR options in an assortment of height, length, width and lordotic angulation combinations to accommodate the unique anatomic and clinical circumstances of each patient.